ERIN Summit Brought Together Patients and Their Families, Offering a Space to Learn, Connect, Feel Supported
EHC – European Haemophilia Consortium shared a post on LinkedIn:
“From 5 to 7 December, we proudly hosted the ERIN Summit in Berlin, Germany. This annual event brings together patients with extremely rare bleeding disorders and their families, offering a unique, family-friendly space to learn, connect, and feel supported.
This year’s programme focused on treatment updates, unmet needs, and lived experiences. Through open discussions and interactive workshops, we strengthened knowledge within the community and built a foundation for continued learning and collaboration.

The tradition of the ERIN summit reflects a long-standing dedication to empowering this community with practical information and advocacy tools. A heartfelt thank-you goes to the ERIN Committee for their ongoing commitment to making patients with extremely rare bleeding disorders more visible and heard. By sharing knowledge and amplifying patient stories, we aim to ensure no one is left behind!
Learn more about the EHC ERIN here”
Get the latest updates with Hemostasis Today.
-
Mar 15, 2026, 15:55Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 2
-
Mar 15, 2026, 14:09Abdul Mannan: A Red Eye, a Blood Clot, and Ibrutinib – The Clinical Tightrope
-
Mar 15, 2026, 14:02Denise M: Precision Hemostasis in Patient Blood Management
-
Mar 15, 2026, 13:57Abdulrahman Nasiri: D14 Bone Marrow Biopsy in AML Induction in the Era of Targeted Therapies
-
Mar 15, 2026, 13:52Valentin Ortiz-Maldonado: High-Impact Innovation in CAR-T Therapy Can Emerge From Academic Programmes
-
Mar 15, 2026, 13:45Tareq Abadl: Has Anyone Here Ever Taken an ALP Test Before?
-
Mar 14, 2026, 21:30Ayman Elbadawi: Why Does Stent Thrombosis Still Occur? Insights from the NCDR Data
-
Mar 14, 2026, 20:03Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
-
Mar 14, 2026, 19:28Vishnu Priya Pulipati: Statins Beyond Cholesterol for Plaque Biology and Cardiovascular Risk Reduction